Literature DB >> 27080465

The Development of Diabetic Retinopathy in Goto-Kakizaki Rat and the Expression of Angiogenesis-Related Signals.

Chen-Yuan Gong1, Bin Lu1, Yu-Chen Sheng2, Zeng-Yang Yu1, Jian-Yuan Zhou1, Li-Li Ji1.   

Abstract

The Goto-Kakizaki (GK) rat is a genetic model of type 2 diabetes. Diabetic retinopathy (DR) is a common complication of diabetes. In this study, we observed the development of DR in GK rats and the expression of some angiogenesis-related signals. GK rats were housed for 5, 6 and 7 months. Results of retinal vessels stained by cluster of differentiation 31 (CD31) showed that the number of retinal vessels was increased in GK rats at both 6 and 7 months. Retinal histological observation also evidenced such increase. Retinal mRNA expression of hypoxia inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF), VEGFB and its receptors (VEGFR1/2), basic fibroblast growth factor (bFGF), and platelet-derived growth factor (PDGF) A/B was increased in GK rats at both 6 and 7 months. Retinal mRNA expressions of matrix metalloproteinase (MMP) 2/9 and insulin-like growth factor 1 (IGF-1) were increased at 7 months. Retinal mRNA expression of pigment epithelium-derived factor (PEDF) was increased in GK rats at 6 months. Serum contents of VEGF, bFGF, PDGFA, MMP2/9, IGF-1, PEDF were increased in GK rats at both 6 and 7 months, while PDGFB was increased at 7 months. In summary, our results indicate that retinal angiogenesis occurred in GK rats at 6 and 7 months, and the expressions of some angiogenesis related factors were increased during the development of DR in GK rats.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27080465     DOI: 10.4077/CJP.2016.BAE383

Source DB:  PubMed          Journal:  Chin J Physiol        ISSN: 0304-4920            Impact factor:   1.764


  6 in total

1.  Differences in the Effects of Pentobarbital Anesthetic and Combination of Medetomidine Hydrochloride, Midazolam, and Butorphanol Tartrate Anesthetic on Electroretinogram in Spontaneously Diabetic Torii Fatty Rats.

Authors:  Tetsuya Hasegawa; Rina Takagi; Yoshiaki Tanaka; Takeshi Ohta; Masami Shinohara; Yasushi Kageyama; Tomohiko Sasase; Shin-Ichi Muramatsu; Toshikatsu Kaburaki; Akihiro Kakehashi
Journal:  Biomed Hub       Date:  2022-09-09

2.  Retinopathy in a Diet-Induced Type 2 Diabetic Rat Model and Role of Epigenetic Modifications.

Authors:  Renu A Kowluru
Journal:  Diabetes       Date:  2020-01-16       Impact factor: 9.461

3.  Serum Vascular Endothelial Growth Factor Levels Correlate with Severity of Retinopathy in Diabetic Patients: A Systematic Review and Meta-Analysis.

Authors:  Zhongwei Zhou; Huixiang Ju; Mingzhong Sun; Hongmei Chen
Journal:  Dis Markers       Date:  2019-03-24       Impact factor: 3.434

4.  Identification of Susceptibility Modules and Genes for Cardiovascular Disease in Diabetic Patients Using WGCNA Analysis.

Authors:  Weiwei Liang; Fangfang Sun; Yiming Zhao; Lizhen Shan; Hanyu Lou
Journal:  J Diabetes Res       Date:  2020-05-10       Impact factor: 4.011

Review 5.  Role of platelet-derived growth factor in type II diabetes mellitus and its complications.

Authors:  Sihong Shen; Fuyan Wang; Alejandra Fernandez; Weining Hu
Journal:  Diab Vasc Dis Res       Date:  2020 Jul-Aug       Impact factor: 3.291

6.  MicroRNA-15b Targets VEGF and Inhibits Angiogenesis in Proliferative Diabetic Retinopathy.

Authors:  Ying Yang; Yan Liu; Yiping Li; Zhongli Chen; Yixin Xiong; Taicheng Zhou; Wenyu Tao; Fan Xu; Hanling Yang; Seppo Ylä-Herttuala; Shyam S Chaurasia; Whaley-Connell Adam; Ke Yang
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.